Lataa...
Therapeutic approaches to slowing the progression of diabetic nephropathy – is less best?
OBJECTIVE: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors are known to reduce proteinuria and have been the first-line agents in the management of diabetic nephropathy for the past 20 years. This review covers recent studies that compare the benefit of add...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Just Medical Media Limited
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3884747/ https://ncbi.nlm.nih.gov/pubmed/24432038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212249 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|